Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

US Patent 7915000 · Granted Mar 29, 2011

Estimated economic value: $47,189,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of disease responsive to modulation of cannabanoid 1(CB1) receptor sig2023
Antibodies that bind human cannabinoid 1 (CB1) receptor2022
Antibodies that bind human cannabinoid 1 (CB1) receptor2019
Rationally designed antibodies2016
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and 2016
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and 2016
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and 2015
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and 2015
Polypeptides and antibodies derived from chronic lymphocytic Leukemia cells and 2015
Polypeptides and antibodies derived from chronic lymphocytic Leukemia cells and 2015
Antibodies to OX-2/CD200 and uses thereof2015
Antibodies to OX-2/CD200 and uses thereof2015